Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal

Abstract

Background: Bibliometric analyses have been used previously to study the measures of quality and impact of research performed in several health-related areas such as adverse drug reactions (ADRs) and pharmacovigilance (PV), etc. This method can assess the research performance of publications quantitatively and statistically. There is no evidence of bibilometric studies analyzing ADRs and PV from Nepal. Therefore, the present study aimed to assess scientific output on ADRs and PV-related research activities in Nepal using a bibliometric analysis of publications from 2004 January to December 2018, that is, 15 years. Methods: A systematic search was conducted in PubMed, Web of Science, Google Scholar, Scopus and Nepal Journal Online (NepJOL) databases. ‘Adverse Drug Reactions‘ or ‘ADRs‘ or ‘ADR‘ or ‘Adverse drug reaction‘ or ‘AE‘ or ‘Adverse Event‘ or ‘Drug-Induced Reaction‘ or ‘Pharmacovigilance‘ or ‘PV‘ and ‘Nepal‘. The search covered 15 years (January 2004 to December 2018) of study on ADRs and PV in Nepal. Only articles retrieved from databases were included, whereas published/unpublished drug bulletins, pharmacy newsletters and thesis were excluded. The articles thus retrieved were recorded, and thereafter analyzed. Word count code was used for the analysis of keywords used in the retrieved articles. Results: A total of 124 articles were retrieved, with the highest rate of publications in 2006 and 2007, with 16 papers each. Among the articles, 10 (8.1%) were published in Kathmandu University Medical Journal (KUMJ). Single papers were published in 38 different journals. Brief reports (1.6%), case reports (31.2%), case series (0.8%), education forums (0.8%), letters to the editor (5.6%), original research articles (41.9%), review articles (9.7%), short communications and short reports (8.1%) on ADRs and PV were recorded. Out of 124 papers, 52 (41.9%) were original research publications. The majority (74.1%) of research was done in the category of ADR incidence, types, prevention, and management, followed by policy and suggestions for strengthening national and regional pharmacovigilance centers of Nepal (14.5%). Conclusions: During the study years, there was an increase in scientific publications on drug safety. A total of 124 published articles were found during bibliometric analysis of ADRs and PV research activities in Nepal.

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems

“…Pharmacovigilance, which relates to the systematic detection, reporting, assessment, understanding, and prevention of adverse reactions [ 58 , 59 ], is an essential aspect of surveillance to ensure the safety of COVID-19 vaccines. Scientists around the globe are working collaboratively to develop safe and effective vaccines to end the pandemic.…”

Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination

“…Monitoring the safety of vaccines is essential to improve safety profiles and enhance public trust. Shrestha et al (2020) described adverse events associated with COVID-19 vaccines and discussed why it is essential to have a functional adverse event monitoring system in this context. Pharmacovigilance and telemedicine are essential aspects of surveillance to ensure the safety of COVID-19 vaccines ( Paudyal et al, 2020 ; Montemurro, 2022 ; Shrestha et al, 2020 ).…”

A Review of the Scientific Contributions of Nepal on COVID-19

“…We can only find a handful of journals with such an analysis. [13,14] Our analysis represents the overall estimates of health research being carried out in Nepal and published in national and international PubMed indexed journals. As with any developing country, there is an underrepresentation of health research studies in Nepal and its publication in international literature.…”